SOUTH SAN FRANCISCO, Calif., Nov. 2, 2011 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report third quarter 2011 results on Wednesday, November 9, 2011. A conference call and webcast hosted by OXiGENE management will begin at 4:30 pm EST (1:30 p.m. PST).
